Pathological Role of Angiotensin II in Severe COVID-19

Abstract

The activated renin–angiotensin system induces a prothrombotic state resulting from the imbalance between coagulation and fibrinolysis. Angiotensin II is the central effector molecule of the activated renin–angiotensin system and is degraded by the angiotensin-converting enzyme 2 to angiotensin (1–7). The novel coronavirus infection (classified as COVID-19) is caused by the new coronavirus SARS-CoV-2 and is characterized by an exaggerated inflammatory response that can lead to severe manifestations such as acute respiratory distress syndrome, sepsis, and death in a proportion of patients, mostly elderly patients with preexisting comorbidities. SARS-CoV-2 uses the angiotensin-converting enzyme 2 receptor to enter the target cells, resulting in activation of the renin–angiotensin system. After downregulating the angiotensin-converting enzyme 2, the vasoconstrictor angiotensin II is increasingly produced and its counterregulating molecules angiotensin (1–7) reduced. Angiotensin II increases thrombin formation and impairs fibrinolysis. Elevated levels were strongly associated with viral load and lung injury in patients with severe COVID-19. Therefore, the complex clinical picture of patients with severe complications of COVID-19 is triggered by the various effects of highly expressed angiotensin II on vasculopathy, coagulopathy, and inflammation. Future treatment options should focus on blocking the thrombogenic and inflammatory properties of angiotensin II in COVID-19 patients.

COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments

“…18,19 A prothrombotic status concurs to the pathology of severe COVID-19 cases, either as a consequence of the hyperactivation of the innate immune system 20 or, as some evidence may suggest, as a direct effect of SARS-CoV2 on the coagulation pathways. 21 In addition, some strains of coronavirus have been shown to activate immune cells in the central nervous system, such as microglial cells, which might be relevant to MS. 22 The role of antibodies and specific T-cell responses in the immune response to coronaviruses. Immune response triggered by coronaviruses involves the activation of specific T cells, production of antibodies, and likely generation of memory B and T cells, as it usually happens after infection with novel pathogens.…”

Targeting coagulation activation in severe COVID-19 pneumonia: lessons from bacterial pneumonia and sepsis

“…Post mortem studies have shown evidence of intracellular virus and microangiopathy [12]. SARS-CoV-2 uses the angiotensin-converting enzyme (ACE)-2 receptor to enter the host cells and activates the renin-angiotensin system, which can induce a prothrombotic state [14]. Furthermore, the host inflammatory response to the virus promotes activation of coagulation and reduced fibrinolysis.…”

Selocalcitol: Scope of inhalational formulation for prevention and cure of COVID-19 illness

“…[16] So, the COVID-19 illness can generate severe respiratory symptoms leading to fatality. [17][18][19] There is considerable current interest in Vitamin D status and COVID-19 illness. [20][21] Many authorities believe that vitamin D de ciency is related to COVID-19 illness.…”